カテゴリー： LP Information, 世界, 医療/バイオ

世界のがん幹細胞（CSC）市場2021-2026：セルサーチ、その他

LP Informationが発行した調査報告書（LPI21MY9460）
◆英語タイトル：Global Cancer Stem Cells (CSCs) Market Growth 2021-2026
◆商品コード：LPI21MY9460
◆発行会社（リサーチ会社）：LP Information
◆発行日：2021年5月（※2024年版があります。お問い合わせください）
◆ページ数：181
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。
LPインフォメーション社の「がん幹細胞（CSC）の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、セルサーチ、その他など、用途別には、乳がん診断・治療、前立腺がん診断・治療、結腸直腸がん診断・治療、肺がん診断・治療、その他がん診断・治療などにセグメント区分してまとめました。がん幹細胞（CSC）のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・がん幹細胞（CSC）の世界市場概要（サマリー）
・がん幹細胞（CSC）の企業別販売量・売上
・がん幹細胞（CSC）の企業別市場シェア
・がん幹細胞（CSC）の世界市場規模 2016年-2021年：種類別（セルサーチ、その他）
・がん幹細胞（CSC）の世界市場規模 2016年-2021年：用途別（乳がん診断・治療、前立腺がん診断・治療、結腸直腸がん診断・治療、肺がん診断・治療、その他がん診断・治療）
・がん幹細胞（CSC）の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・がん幹細胞（CSC）のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・がん幹細胞（CSC）のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・がん幹細胞（CSC）の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・がん幹細胞（CSC）市場の成長要因・課題・動向
・がん幹細胞（CSC）の世界市場予測 2021年-2026年
・がん幹細胞（CSC）の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・がん幹細胞（CSC）のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・がん幹細胞（CSC）のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・がん幹細胞（CSC）の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・がん幹細胞（CSC）の世界市場予測：種類別（セルサーチ、その他）
・がん幹細胞（CSC）の世界市場予測：用途別（乳がん診断・治療、前立腺がん診断・治療、結腸直腸がん診断・治療、肺がん診断・治療、その他がん診断・治療）
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Cancer Stem Cells (CSCs) will have significant change from previous year. By the most conservative estimates of global Cancer Stem Cells (CSCs) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Cancer Stem Cells (CSCs) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Stem Cells (CSCs) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
CellSearch
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Breast Cancer Diagnosis and Treatment
Prostate Cancer Diagnosis and Treatment
Colorectal Cancer Diagnosis and Treatment
Lung Cancer Diagnosis and Treatment
Other Cancers Diagnosis and Treatment

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Janssen
Qiagen
Advanced Cell Diagnostics
ApoCell
Biofluidica
Clearbridge Biomedics
CytoTrack
Celsee
Fluxion
Gilupi
Cynvenio
On-chip
YZY Bio
BioView
Creatv MicroTech
Fluidigm
Ikonisys
AdnaGen
IVDiagnostics
Miltenyi Biotec
Aviva Biosciences Corporation
ScreenCell
Silicon Biosystems

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cancer Stem Cells (CSCs) Consumption 2016-2026
2.1.2 Cancer Stem Cells (CSCs) Consumption CAGR by Region
2.2 Cancer Stem Cells (CSCs) Segment by Type
2.2.1 CellSearch
2.2.2 Others
2.3 Cancer Stem Cells (CSCs) Sales by Type
2.3.1 Global Cancer Stem Cells (CSCs) Sales Market Share by Type (2016-2021)
2.3.2 Global Cancer Stem Cells (CSCs) Revenue and Market Share by Type (2016-2021)
2.3.3 Global Cancer Stem Cells (CSCs) Sale Price by Type (2016-2021)
2.4 Cancer Stem Cells (CSCs) Segment by Application
2.4.1 Breast Cancer Diagnosis and Treatment
2.4.2 Prostate Cancer Diagnosis and Treatment
2.4.3 Colorectal Cancer Diagnosis and Treatment
2.4.4 Lung Cancer Diagnosis and Treatment
2.4.5 Other Cancers Diagnosis and Treatment
2.5 Cancer Stem Cells (CSCs) Sales by Application
2.5.1 Global Cancer Stem Cells (CSCs) Sale Market Share by Application (2016-2021)
2.5.2 Global Cancer Stem Cells (CSCs) Revenue and Market Share by Application (2016-2021)
2.5.3 Global Cancer Stem Cells (CSCs) Sale Price by Application (2016-2021)

3 Global Cancer Stem Cells (CSCs) by Company
3.1 Global Cancer Stem Cells (CSCs) Sales Market Share by Company
3.1.1 Global Cancer Stem Cells (CSCs) Sales by Company (2019-2021)
3.1.2 Global Cancer Stem Cells (CSCs) Sales Market Share by Company (2019-2021)
3.2 Global Cancer Stem Cells (CSCs) Revenue Market Share by Company
3.2.1 Global Cancer Stem Cells (CSCs) Revenue by Company (2019-2021)
3.2.2 Global Cancer Stem Cells (CSCs) Revenue Market Share by Company (2019-2021)
3.3 Global Cancer Stem Cells (CSCs) Sale Price by Company
3.4 Global Manufacturers Cancer Stem Cells (CSCs) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cancer Stem Cells (CSCs) Product Location Distribution
3.4.2 Players Cancer Stem Cells (CSCs) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Cancer Stem Cells (CSCs) by Region
4.1 Global Cancer Stem Cells (CSCs) by Region
4.1.1 Global Cancer Stem Cells (CSCs) Sales by Region
4.1.2 Global Cancer Stem Cells (CSCs) Revenue by Region
4.2 Americas Cancer Stem Cells (CSCs) Sales Growth
4.3 APAC Cancer Stem Cells (CSCs) Sales Growth
4.4 Europe Cancer Stem Cells (CSCs) Sales Growth
4.5 Middle East & Africa Cancer Stem Cells (CSCs) Sales Growth

5 Americas
5.1 Americas Cancer Stem Cells (CSCs) Sales by Country
5.1.1 Americas Cancer Stem Cells (CSCs) Sales by Country (2016-2021)
5.1.2 Americas Cancer Stem Cells (CSCs) Revenue by Country (2016-2021)
5.2 Americas Cancer Stem Cells (CSCs) Sales by Type
5.3 Americas Cancer Stem Cells (CSCs) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Cancer Stem Cells (CSCs) Sales by Region
6.1.1 APAC Cancer Stem Cells (CSCs) Sales by Region (2016-2021)
6.1.2 APAC Cancer Stem Cells (CSCs) Revenue by Region (2016-2021)
6.2 APAC Cancer Stem Cells (CSCs) Sales by Type
6.3 APAC Cancer Stem Cells (CSCs) Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Cancer Stem Cells (CSCs) by Country
7.1.1 Europe Cancer Stem Cells (CSCs) Sales by Country (2016-2021)
7.1.2 Europe Cancer Stem Cells (CSCs) Revenue by Country (2016-2021)
7.2 Europe Cancer Stem Cells (CSCs) Sales by Type
7.3 Europe Cancer Stem Cells (CSCs) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Cancer Stem Cells (CSCs) by Country
8.1.1 Middle East & Africa Cancer Stem Cells (CSCs) Sales by Country (2016-2021)
8.1.2 Middle East & Africa Cancer Stem Cells (CSCs) Revenue by Country (2016-2021)
8.2 Middle East & Africa Cancer Stem Cells (CSCs) Sales by Type
8.3 Middle East & Africa Cancer Stem Cells (CSCs) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Cancer Stem Cells (CSCs) Distributors
10.3 Cancer Stem Cells (CSCs) Customer

11 Global Cancer Stem Cells (CSCs) Market Forecast
11.1 Global Cancer Stem Cells (CSCs) Forecast by Region
11.1.1 Global Cancer Stem Cells (CSCs) Forecast by Regions (2021-2026)
11.2.2 Global Cancer Stem Cells (CSCs) Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Cancer Stem Cells (CSCs) Forecast by Type
11.7 Global Cancer Stem Cells (CSCs) Forecast by Application

12 Key Players Analysis
12.1 Janssen
12.1.1 Janssen Janssen Company Information
12.1.2 Janssen Cancer Stem Cells (CSCs) Product Offered
12.1.3 Janssen Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Janssen Main Business Overview
12.1.5 Janssen Latest Developments
12.2 Qiagen
12.2.1 Qiagen Company Information
12.2.2 Qiagen Cancer Stem Cells (CSCs) Product Offered
12.2.3 Qiagen Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Qiagen Main Business Overview
12.2.5 Qiagen Latest Developments
12.3 Advanced Cell Diagnostics
12.3.1 Advanced Cell Diagnostics Company Information
12.3.2 Advanced Cell Diagnostics Cancer Stem Cells (CSCs) Product Offered
12.3.3 Advanced Cell Diagnostics Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Advanced Cell Diagnostics Main Business Overview
12.3.5 Advanced Cell Diagnostics Latest Developments
12.4 ApoCell
12.4.1 ApoCell Company Information
12.4.2 ApoCell Cancer Stem Cells (CSCs) Product Offered
12.4.3 ApoCell Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 ApoCell Main Business Overview
12.4.5 ApoCell Latest Developments
12.5 Biofluidica
12.5.1 Biofluidica Company Information
12.5.2 Biofluidica Cancer Stem Cells (CSCs) Product Offered
12.5.3 Biofluidica Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Biofluidica Main Business Overview
12.5.5 Biofluidica Latest Developments
12.6 Clearbridge Biomedics
12.6.1 Clearbridge Biomedics Company Information
12.6.2 Clearbridge Biomedics Cancer Stem Cells (CSCs) Product Offered
12.6.3 Clearbridge Biomedics Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Clearbridge Biomedics Main Business Overview
12.6.5 Clearbridge Biomedics Latest Developments
12.7 CytoTrack
12.7.1 CytoTrack Company Information
12.7.2 CytoTrack Cancer Stem Cells (CSCs) Product Offered
12.7.3 CytoTrack Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 CytoTrack Main Business Overview
12.7.5 CytoTrack Latest Developments
12.8 Celsee
12.8.1 Celsee Company Information
12.8.2 Celsee Cancer Stem Cells (CSCs) Product Offered
12.8.3 Celsee Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Celsee Main Business Overview
12.8.5 Celsee Latest Developments
12.9 Fluxion
12.9.1 Fluxion Company Information
12.9.2 Fluxion Cancer Stem Cells (CSCs) Product Offered
12.9.3 Fluxion Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Fluxion Main Business Overview
12.9.5 Fluxion Latest Developments
12.10 Gilupi
12.10.1 Gilupi Company Information
12.10.2 Gilupi Cancer Stem Cells (CSCs) Product Offered
12.10.3 Gilupi Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Gilupi Main Business Overview
12.10.5 Gilupi Latest Developments
12.11 Cynvenio
12.11.1 Cynvenio Company Information
12.11.2 Cynvenio Cancer Stem Cells (CSCs) Product Offered
12.11.3 Cynvenio Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Cynvenio Main Business Overview
12.11.5 Cynvenio Latest Developments
12.12 On-chip
12.12.1 On-chip Company Information
12.12.2 On-chip Cancer Stem Cells (CSCs) Product Offered
12.12.3 On-chip Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 On-chip Main Business Overview
12.12.5 On-chip Latest Developments
12.13 YZY Bio
12.13.1 YZY Bio Company Information
12.13.2 YZY Bio Cancer Stem Cells (CSCs) Product Offered
12.13.3 YZY Bio Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 YZY Bio Main Business Overview
12.13.5 YZY Bio Latest Developments
12.14 BioView
12.14.1 BioView Company Information
12.14.2 BioView Cancer Stem Cells (CSCs) Product Offered
12.14.3 BioView Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 BioView Main Business Overview
12.14.5 BioView Latest Developments
12.15 Creatv MicroTech
12.15.1 Creatv MicroTech Company Information
12.15.2 Creatv MicroTech Cancer Stem Cells (CSCs) Product Offered
12.15.3 Creatv MicroTech Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Creatv MicroTech Main Business Overview
12.15.5 Creatv MicroTech Latest Developments
12.16 Fluidigm
12.16.1 Fluidigm Company Information
12.16.2 Fluidigm Cancer Stem Cells (CSCs) Product Offered
12.16.3 Fluidigm Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Fluidigm Main Business Overview
12.16.5 Fluidigm Latest Developments
12.17 Ikonisys
12.17.1 Ikonisys Company Information
12.17.2 Ikonisys Cancer Stem Cells (CSCs) Product Offered
12.17.3 Ikonisys Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Ikonisys Main Business Overview
12.17.5 Ikonisys Latest Developments
12.18 AdnaGen
12.18.1 AdnaGen Company Information
12.18.2 AdnaGen Cancer Stem Cells (CSCs) Product Offered
12.18.3 AdnaGen Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.18.4 AdnaGen Main Business Overview
12.18.5 AdnaGen Latest Developments
12.19 IVDiagnostics
12.19.1 IVDiagnostics Company Information
12.19.2 IVDiagnostics Cancer Stem Cells (CSCs) Product Offered
12.19.3 IVDiagnostics Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.19.4 IVDiagnostics Main Business Overview
12.19.5 IVDiagnostics Latest Developments
12.20 Miltenyi Biotec
12.20.1 Miltenyi Biotec Company Information
12.20.2 Miltenyi Biotec Cancer Stem Cells (CSCs) Product Offered
12.20.3 Miltenyi Biotec Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.20.4 Miltenyi Biotec Main Business Overview
12.20.5 Miltenyi Biotec Latest Developments
12.21 Aviva Biosciences Corporation
12.21.1 Aviva Biosciences Corporation Company Information
12.21.2 Aviva Biosciences Corporation Cancer Stem Cells (CSCs) Product Offered
12.21.3 Aviva Biosciences Corporation Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.21.4 Aviva Biosciences Corporation Main Business Overview
12.21.5 Aviva Biosciences Corporation Latest Developments
12.22 ScreenCell
12.22.1 ScreenCell Company Information
12.22.2 ScreenCell Cancer Stem Cells (CSCs) Product Offered
12.22.3 ScreenCell Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.22.4 ScreenCell Main Business Overview
12.22.5 ScreenCell Latest Developments
12.23 Silicon Biosystems
12.23.1 Silicon Biosystems Company Information
12.23.2 Silicon Biosystems Cancer Stem Cells (CSCs) Product Offered
12.23.3 Silicon Biosystems Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2019-2021)
12.23.4 Silicon Biosystems Main Business Overview
12.23.5 Silicon Biosystems Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Cancer Stem Cells (CSCs) Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of CellSearch
Table 3. Major Players of Others
Table 4. Global Cancer Stem Cells (CSCs) Sales by Type (2016-2021) & (K Units)
Table 5. Global Cancer Stem Cells (CSCs) Sales Market Share by Type (2016-2021)
Table 6. Global Cancer Stem Cells (CSCs) Revenue by Type (2016-2021) & ($ million)
Table 7. Global Cancer Stem Cells (CSCs) Revenue Market Share by Type (2016-2021)
Table 8. Global Cancer Stem Cells (CSCs) Sale Price by Type (2016-2021)
Table 9. Global Cancer Stem Cells (CSCs) Sales by Application (2016-2021) & (K Units)
Table 10. Global Cancer Stem Cells (CSCs) Sales Market Share by Application (2016-2021)
Table 11. Global Cancer Stem Cells (CSCs) Value by Application (2016-2021)
Table 12. Global Cancer Stem Cells (CSCs) Revenue Market Share by Application (2016-2021)
Table 13. Global Cancer Stem Cells (CSCs) Sale Price by Application (2016-2021)
Table 14. Global Cancer Stem Cells (CSCs) Sales by Company (2019-2021) & (K Units)
Table 15. Global Cancer Stem Cells (CSCs) Sales Market Share by Company (2019-2021)
Table 16. Global Cancer Stem Cells (CSCs) Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Cancer Stem Cells (CSCs) Revenue Market Share by Company (2019-2021)
Table 18. Global Cancer Stem Cells (CSCs) Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Cancer Stem Cells (CSCs) Producing Area Distribution and Sales Area
Table 20. Players Cancer Stem Cells (CSCs) Products Offered
Table 21. Cancer Stem Cells (CSCs) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Cancer Stem Cells (CSCs) Sales by Region (2016-2021) (K Units)
Table 25. Global Cancer Stem Cells (CSCs) Sales Market Share by Region (2016-2021)
Table 26. Global Cancer Stem Cells (CSCs) Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Cancer Stem Cells (CSCs) Revenue Market Share by Region (2016-2021)
Table 28. Americas Cancer Stem Cells (CSCs) Sales by Country (2016-2021) & (K Units)
Table 29. Americas Cancer Stem Cells (CSCs) Sales Market Share by Country (2016-2021)
Table 30. Americas Cancer Stem Cells (CSCs) Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Cancer Stem Cells (CSCs) Revenue Market Share by Country (2016-2021)
Table 32. Americas Cancer Stem Cells (CSCs) Sales by Type (2016-2021) & (K Units)
Table 33. Americas Cancer Stem Cells (CSCs) Sales Market Share by Type (2016-2021)
Table 34. Americas Cancer Stem Cells (CSCs) Sales by Application (2016-2021) & (K Units)
Table 35. Americas Cancer Stem Cells (CSCs) Sales Market Share by Application (2016-2021)
Table 36. APAC Cancer Stem Cells (CSCs) Sales by Region (2016-2021) & (K Units)
Table 37. APAC Cancer Stem Cells (CSCs) Sales Market Share by Region (2016-2021)
Table 38. APAC Cancer Stem Cells (CSCs) Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Cancer Stem Cells (CSCs) Revenue Market Share by Region (2016-2021)
Table 40. APAC Cancer Stem Cells (CSCs) Sales by Type (2016-2021) & (K Units)
Table 41. APAC Cancer Stem Cells (CSCs) Sales Market Share by Type (2016-2021)
Table 42. APAC Cancer Stem Cells (CSCs) Sales by Application (2016-2021) & (K Units)
Table 43. APAC Cancer Stem Cells (CSCs) Sales Market Share by Application (2016-2021)
Table 44. Europe Cancer Stem Cells (CSCs) Sales by Country (2016-2021) & (K Units)
Table 45. Europe Cancer Stem Cells (CSCs) Sales Market Share by Country (2016-2021)
Table 46. Europe Cancer Stem Cells (CSCs) Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Cancer Stem Cells (CSCs) Revenue Market Share by Country (2016-2021)
Table 48. Europe Cancer Stem Cells (CSCs) Sales by Type (2016-2021) & (K Units)
Table 49. Europe Cancer Stem Cells (CSCs) Sales Market Share by Type (2016-2021)
Table 50. Europe Cancer Stem Cells (CSCs) Sales by Application (2016-2021) & (K Units)
Table 51. Europe Cancer Stem Cells (CSCs) Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Cancer Stem Cells (CSCs) Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Cancer Stem Cells (CSCs) Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Cancer Stem Cells (CSCs) Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Cancer Stem Cells (CSCs) Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Cancer Stem Cells (CSCs) Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Cancer Stem Cells (CSCs) Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Cancer Stem Cells (CSCs) Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa Cancer Stem Cells (CSCs) Sales Market Share by Application (2016-2021)
Table 60. Global Cancer Stem Cells (CSCs) Sales Forecast by Type (2021-2026) & (K Units)
Table 61. Global Cancer Stem Cells (CSCs) Sales Market Share Forecast by Type (2021-2026)
Table 62. Global Cancer Stem Cells (CSCs) Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 63. Global Cancer Stem Cells (CSCs) Revenue Market Share Forecast by Type (2021-2026)
Table 64. Global Cancer Stem Cells (CSCs) Sales Forecast by Application (2021-2026) & (K Units)
Table 65. Global Cancer Stem Cells (CSCs) Sales Market Share Forecast by Application (2021-2026)
Table 66. Global Cancer Stem Cells (CSCs) Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 67. Global Cancer Stem Cells (CSCs) Revenue Market Share Forecast by Application (2021-2026)
Table 68. Janssen Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 69. Janssen Cancer Stem Cells (CSCs) Product Offered
Table 70. Janssen Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 71. Janssen Main Business
Table 72. Janssen Latest Developments
Table 73. Qiagen Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 74. Qiagen Cancer Stem Cells (CSCs) Product Offered
Table 75. Qiagen Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 76. Qiagen Main Business
Table 77. Qiagen Latest Developments
Table 78. Advanced Cell Diagnostics Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 79. Advanced Cell Diagnostics Cancer Stem Cells (CSCs) Product Offered
Table 80. Advanced Cell Diagnostics Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 81. Advanced Cell Diagnostics Main Business
Table 82. Advanced Cell Diagnostics Latest Developments
Table 83. ApoCell Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 84. ApoCell Cancer Stem Cells (CSCs) Product Offered
Table 85. ApoCell Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 86. ApoCell Main Business
Table 87. ApoCell Latest Developments
Table 88. Biofluidica Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 89. Biofluidica Cancer Stem Cells (CSCs) Product Offered
Table 90. Biofluidica Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 91. Biofluidica Main Business
Table 92. Biofluidica Latest Developments
Table 93. Clearbridge Biomedics Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 94. Clearbridge Biomedics Cancer Stem Cells (CSCs) Product Offered
Table 95. Clearbridge Biomedics Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 96. Clearbridge Biomedics Main Business
Table 97. Clearbridge Biomedics Latest Developments
Table 98. CytoTrack Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 99. CytoTrack Cancer Stem Cells (CSCs) Product Offered
Table 100. CytoTrack Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 101. CytoTrack Main Business
Table 102. CytoTrack Latest Developments
Table 103. Celsee Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 104. Celsee Cancer Stem Cells (CSCs) Product Offered
Table 105. Celsee Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 106. Celsee Main Business
Table 107. Celsee Latest Developments
Table 108. Fluxion Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 109. Fluxion Cancer Stem Cells (CSCs) Product Offered
Table 110. Fluxion Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 111. Fluxion Main Business
Table 112. Fluxion Latest Developments
Table 113. Gilupi Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 114. Gilupi Cancer Stem Cells (CSCs) Product Offered
Table 115. Gilupi Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 116. Gilupi Main Business
Table 117. Gilupi Latest Developments
Table 118. Cynvenio Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 119. Cynvenio Cancer Stem Cells (CSCs) Product Offered
Table 120. Cynvenio Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 121. Cynvenio Main Business
Table 122. Cynvenio Latest Developments
Table 123. On-chip Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 124. On-chip Cancer Stem Cells (CSCs) Product Offered
Table 125. On-chip Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 126. On-chip Main Business
Table 127. On-chip Latest Developments
Table 128. YZY Bio Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 129. YZY Bio Cancer Stem Cells (CSCs) Product Offered
Table 130. YZY Bio Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 131. YZY Bio Main Business
Table 132. YZY Bio Latest Developments
Table 133. BioView Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 134. BioView Cancer Stem Cells (CSCs) Product Offered
Table 135. BioView Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 136. BioView Main Business
Table 137. BioView Latest Developments
Table 138. Creatv MicroTech Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 139. Creatv MicroTech Cancer Stem Cells (CSCs) Product Offered
Table 140. Creatv MicroTech Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 141. Creatv MicroTech Main Business
Table 142. Creatv MicroTech Latest Developments
Table 143. Fluidigm Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 144. Fluidigm Cancer Stem Cells (CSCs) Product Offered
Table 145. Fluidigm Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 146. Fluidigm Main Business
Table 147. Fluidigm Latest Developments
Table 148. Ikonisys Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 149. Ikonisys Cancer Stem Cells (CSCs) Product Offered
Table 150. Ikonisys Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 151. Ikonisys Main Business
Table 152. Ikonisys Latest Developments
Table 153. AdnaGen Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 154. AdnaGen Cancer Stem Cells (CSCs) Product Offered
Table 155. AdnaGen Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 156. AdnaGen Main Business
Table 157. AdnaGen Latest Developments
Table 158. IVDiagnostics Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 159. IVDiagnostics Cancer Stem Cells (CSCs) Product Offered
Table 160. IVDiagnostics Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 161. IVDiagnostics Main Business
Table 162. IVDiagnostics Latest Developments
Table 163. Miltenyi Biotec Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 164. Miltenyi Biotec Cancer Stem Cells (CSCs) Product Offered
Table 165. Miltenyi Biotec Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 166. Miltenyi Biotec Main Business
Table 167. Miltenyi Biotec Latest Developments
Table 168. Aviva Biosciences Corporation Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 169. Aviva Biosciences Corporation Cancer Stem Cells (CSCs) Product Offered
Table 170. Aviva Biosciences Corporation Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 171. Aviva Biosciences Corporation Main Business
Table 172. Aviva Biosciences Corporation Latest Developments
Table 173. ScreenCell Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 174. ScreenCell Cancer Stem Cells (CSCs) Product Offered
Table 175. ScreenCell Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 176. ScreenCell Main Business
Table 177. ScreenCell Latest Developments
Table 178. Silicon Biosystems Basic Information, Cancer Stem Cells (CSCs) Manufacturing Base, Sales Area and Its Competitors
Table 179. Silicon Biosystems Cancer Stem Cells (CSCs) Product Offered
Table 180. Silicon Biosystems Cancer Stem Cells (CSCs) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 181. Silicon Biosystems Main Business
Table 182. Silicon Biosystems Latest Developments
List of Figures
Figure 1. Picture of Cancer Stem Cells (CSCs)
Figure 2. Cancer Stem Cells (CSCs) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cancer Stem Cells (CSCs) Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Cancer Stem Cells (CSCs) Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Cancer Stem Cells (CSCs) Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of CellSearch
Figure 10. Product Picture of Others
Figure 11. Global Cancer Stem Cells (CSCs) Sales Market Share by Type in 2020
Figure 12. Global Cancer Stem Cells (CSCs) Revenue Market Share by Type (2016-2021)
Figure 13. Cancer Stem Cells (CSCs) Consumed in Breast Cancer Diagnosis and Treatment
Figure 14. Global Cancer Stem Cells (CSCs) Market: Breast Cancer Diagnosis and Treatment (2016-2021) & (K Units)
Figure 15. Cancer Stem Cells (CSCs) Consumed in Prostate Cancer Diagnosis and Treatment
Figure 16. Global Cancer Stem Cells (CSCs) Market: Prostate Cancer Diagnosis and Treatment (2016-2021) & (K Units)
Figure 17. Cancer Stem Cells (CSCs) Consumed in Colorectal Cancer Diagnosis and Treatment
Figure 18. Global Cancer Stem Cells (CSCs) Market: Colorectal Cancer Diagnosis and Treatment (2016-2021) & (K Units)
Figure 19. Cancer Stem Cells (CSCs) Consumed in Lung Cancer Diagnosis and Treatment
Figure 20. Global Cancer Stem Cells (CSCs) Market: Lung Cancer Diagnosis and Treatment (2016-2021) & (K Units)
Figure 21. Cancer Stem Cells (CSCs) Consumed in Other Cancers Diagnosis and Treatment
Figure 22. Global Cancer Stem Cells (CSCs) Market: Other Cancers Diagnosis and Treatment (2016-2021) & (K Units)
Figure 23. Global Cancer Stem Cells (CSCs) Sales Market Share by Application (2016-2021)
Figure 24. Global Cancer Stem Cells (CSCs) Revenue Market Share by Application in 2020
Figure 25. Global Cancer Stem Cells (CSCs) Revenue Market by Company in 2020 ($ Million)
Figure 26. Global Cancer Stem Cells (CSCs) Revenue Market Share by Company in 2020
Figure 27. Global Cancer Stem Cells (CSCs) Sales Market Share by Regions (2016-2021)
Figure 28. Global Cancer Stem Cells (CSCs) Revenue Market Share by Region in 2020
Figure 29. Americas Cancer Stem Cells (CSCs) Sales 2016-2021 (K Units)
Figure 30. Americas Cancer Stem Cells (CSCs) Revenue 2016-2021 ($ Millions)
Figure 31. APAC Cancer Stem Cells (CSCs) Sales 2016-2021 (K Units)
Figure 32. APAC Cancer Stem Cells (CSCs) Revenue 2016-2021 ($ Millions)
Figure 33. Europe Cancer Stem Cells (CSCs) Sales 2016-2021 (K Units)
Figure 34. Europe Cancer Stem Cells (CSCs) Revenue 2016-2021 ($ Millions)
Figure 35. Middle East & Africa Cancer Stem Cells (CSCs) Sales 2016-2021 (K Units)
Figure 36. Middle East & Africa Cancer Stem Cells (CSCs) Revenue 2016-2021 ($ Millions)
Figure 37. Americas Cancer Stem Cells (CSCs) Sales Market Share by Country in 2020
Figure 38. Americas Cancer Stem Cells (CSCs) Revenue Market Share by Country in 2020
Figure 39. Americas Cancer Stem Cells (CSCs) Sales Market Share by Type in 2020
Figure 40. Americas Cancer Stem Cells (CSCs) Sales Market Share by Application in 2020
Figure 41. United States Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 42. Canada Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 43. Mexico Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 44. Brazil Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 45. APAC Cancer Stem Cells (CSCs) Sales Market Share by Region in 2020
Figure 46. APAC Cancer Stem Cells (CSCs) Revenue Market Share by Regions in 2020
Figure 47. APAC Cancer Stem Cells (CSCs) Sales Market Share by Type in 2020
Figure 48. APAC Cancer Stem Cells (CSCs) Sales Market Share by Application in 2020
Figure 49. China Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 50. Japan Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 51. Korea Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 52. Southeast Asia Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 53. India Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 54. Australia Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 55. Europe Cancer Stem Cells (CSCs) Sales Market Share by Country in 2020
Figure 56. Europe Cancer Stem Cells (CSCs) Revenue Market Share by Country in 2020
Figure 57. Europe Cancer Stem Cells (CSCs) Sales Market Share by Type in 2020
Figure 58. Europe Cancer Stem Cells (CSCs) Sales Market Share by Application in 2020
Figure 59. Germany Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 60. France Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 61. UK Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 62. Italy Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 63. Russia Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 64. Middle East & Africa Cancer Stem Cells (CSCs) Sales Market Share by Country in 2020
Figure 65. Middle East & Africa Cancer Stem Cells (CSCs) Revenue Market Share by Country in 2020
Figure 66. Middle East & Africa Cancer Stem Cells (CSCs) Sales Market Share by Type in 2020
Figure 67. Middle East & Africa Cancer Stem Cells (CSCs) Sales Market Share by Application in 2020
Figure 68. Egypt Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 69. South Africa Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 70. Israel Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 71. Turkey Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 72. GCC Country Cancer Stem Cells (CSCs) Revenue Growth 2016-2021 ($ Millions)
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles


【免責事項】
https://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界のがん幹細胞（CSC）市場2021-2026：セルサーチ、その他(Global Cancer Stem Cells (CSCs) Market Growth 2021-2026)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の内部固定グループプレート市場2021-2026：大型プレート、小型プレート、ミニプレート
  • 世界の採血・処理・管理装置・消耗品市場2021-2026：装置、消耗品、ソフトウェア、サービス
  • 世界の凍結乾燥薬再構成用SWFI市場2021-2026：バイアル、プレフィルドシリンジ
  • 世界の双極性障害治療薬市場2021-2026：気分安定薬、抗精神病薬、抗うつ薬、その他薬品
  • 世界の共焦点イメージング顕微鏡市場2021-2026：レーザー走査型顕微鏡、スピニングディスク共焦点顕微鏡、プログラマブルアレイ顕微鏡（PAM）
  • 世界のプレフィルドシリンジバレル市場2021-2026：プラスチック、ガラス
  • 世界の歯科用3Dスキャナー市場2021-2026：デスクトップ型・研究所用3Dデンタルスキャナー、口腔内用3Dデンタルスキャナー、ハンドヘルド型3Dデンタルスキャナー、コーンビームコンピューター断層撮影（CBCT）
  • 世界の医療用防護服市場2021-2026：手術用衣類、日常用作業服、特別用保護服
  • 世界の低温プラズマ滅菌器市場2021-2026：100 L以下、100〜200 L、200L以上
  • 世界のパウダーフリーニトリル使い捨て手袋市場2021-2026：滅菌ニトリル手袋、非滅菌ニトリル手袋
  • 世界のベタメタゾン軟膏市場2021-2026：ジプロピオン酸ベタメタゾン、リン酸ベタメタゾンナトリウム、吉草酸ベタメタゾン
  • 世界の微細藻類製品市場2021-2026：アスタキサンチン、B-カロテン、スピルリナ、クロレラ、PUFA、ルテイン、その他
  • 世界の医療機器光源市場2021-2026：LED光源、キセノン光源、その他
  • 世界のハイドレーションブラダー市場2021-2026：プラスチック、合成
  • 世界の医療用ルーペ市場2021-2026：レンズルーペ（TTL）、フリップアップルーペ、ガリレオルーペ、プリズマティックルーペ